A. Bakardjiev, P. Barnes, L. Goumnerova, P. Black, R. Scott et al., Magnetic resonance imaging changes after stereotactic radiation therapy for childhood low grade astrocytoma, Cancer, vol.13, issue.4, pp.864-873, 1996.
DOI : 10.1002/(SICI)1097-0142(19960815)78:4<864::AID-CNCR25>3.0.CO;2-S

T. Sugahara, Y. Korogi, S. Tomiguchi, Y. Shigematsu, I. Ikushima et al., Posttherapeutic intra-axial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from non-neoplastic contrast enhancing tissue, AJNR Am J Neuroradiol, vol.21, pp.901-909, 2000.

D. Wit, H. De-bruin, W. Eljkenboom, S. Smitt, and P. , Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression, Neurology, vol.63, issue.3, pp.535-537, 2004.
DOI : 10.1212/01.WNL.0000133398.11870.9A

M. Chamberlain, M. Glantz, L. Chalmers, A. Van-horn, and A. Sloan, Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma, Journal of Neuro-Oncology, vol.63, issue.1, pp.81-83, 2007.
DOI : 10.1007/s11060-006-9241-y

W. Taal, D. Brandsma, H. De-bruin, J. Bromberg, A. Swaak-kragten et al., Incidence of early pseudo???progression in a cohort of malignant glioma patients treated with chemoirradiation with temozolomide, Cancer, vol.68, issue.2, pp.405-410, 2008.
DOI : 10.1002/cncr.23562

D. Brandsma, L. Stalpers, W. Taal, and P. Sminia, Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas, The Lancet Oncology, vol.9, issue.5, pp.453-461, 2008.
DOI : 10.1016/S1470-2045(08)70125-6

L. Lafay-cousin, J. Feniak, B. Wilson, X. Wei, C. Rotaru et al., Pseudoprogression in pediatric diffuse pontine glioma treated with radiation and concomitant temozolomide, p.393, 2008.

Y. Cao, Z. Shen, T. Chenevert, and J. Ewing, Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI, Journal of Magnetic Resonance Imaging, vol.21, issue.2, pp.288-296, 2006.
DOI : 10.1002/jmri.20634

J. Boxerman, K. Schmainda, and R. Weisskoff, Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not, AJNR Am J Neuroradiol, vol.27, pp.859-867, 2006.

F. Dhermain, G. Saliou, F. Parker, P. Page, K. Hoang-xuan et al., Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas, Journal of Neuro-Oncology, vol.178, issue.Suppl 7, 2009.
DOI : 10.1007/s11060-009-9992-3

L. Hu, L. Baxter, K. Smith, B. Feuerstein, J. Karis et al., Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements, American Journal of Neuroradiology, vol.30, issue.3, pp.552-558, 2009.
DOI : 10.3174/ajnr.A1377

V. Ridola, J. Grill, F. Doz, J. Gentet, D. Frappaz et al., High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapy, Cancer, vol.22, issue.1, pp.156-63, 2007.
DOI : 10.1002/cncr.22761

F. Spreafico, L. Gandola, A. Marchiano, F. Simonetti, G. Poggi et al., Brain Magnetic Resonance Imaging After High-Dose Chemotherapy and Radiotherapy for Childhood Brain Tumors, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.4, pp.1011-1020, 2008.
DOI : 10.1016/j.ijrobp.2007.07.2377

M. Fouladi, M. Chintagumpala, F. Laningham, D. Ashley, S. Kellie et al., White Matter Lesions Detected by Magnetic Resonance Imaging After Radiotherapy and High-Dose Chemotherapy in Children With Medulloblastoma or Primitive Neuroectodermal Tumor, Journal of Clinical Oncology, vol.22, issue.22, pp.4551-60, 2004.
DOI : 10.1200/JCO.2004.03.058

A. Brandes, A. Tosconi, F. Spagnolli, G. Frezza, M. Leonardi et al., Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology, Neuro-Oncology, vol.10, issue.3, pp.361-367, 2008.
DOI : 10.1215/15228517-2008-008

H. Schlemmer, P. Bachert, K. Herfarth, I. Zuna, J. Debus et al., Proton MR spectroscopic evaluation of suspicious brain lesions after stereotactic radiotherapy, AJNR Am J Neuroradiol, vol.22, pp.1316-1324, 2001.

Q. Zeng, C. Li, H. Liu, J. Zhen, and D. Feng, Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in Meyzer et al. Radiation Oncology, 2010.

J. Rock, L. Scarpace, D. Hearshen, J. Gutierrez, J. Fisher et al., Associations among Magnetic Resonance Spectroscopy, Apparent Diffusion Coefficients, and Image-Guided Histopathology with Special Attention to Radiation Necrosis, Neurosurgery, vol.54, issue.5, pp.1111-1119, 2004.
DOI : 10.1227/01.NEU.0000119328.56431.A7

Y. Terakawa, N. Tsuyuguchi, Y. Iwai, K. Yamanaka, S. Higashiyama et al., Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy, Journal of Nuclear Medicine, vol.49, issue.5, pp.694-99, 2008.
DOI : 10.2967/jnumed.107.048082

R. Barajas, . Jr, J. Chang, M. Segal, A. Parsa et al., Differentiation of Recurrent Glioblastoma Multiforme from Radiation Necrosis after External Beam Radiation Therapy with Dynamic Susceptibility-weighted Contrast-enhanced Perfusion MR Imaging, Radiology, vol.253, issue.2, pp.486-496, 2009.
DOI : 10.1148/radiol.2532090007

V. Dandois, D. Rommel, R. L. Jamart, J. Cosnard, and G. , Substitution of 11 Cmethionine PET by perfusion MRI during the follow-up of treated highgrade gliomas: preliminary results in clinical practice, J Neuroradiol, 2009.

W. Mason, D. Maestro, M. Eisenstat, D. Forsyth, P. Fulton et al., Canadian Recommendations for the Treatment of Glioblastoma Multiforme, Current Oncology, vol.14, issue.3, pp.110-117, 2007.
DOI : 10.3747/co.2007.119